This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human sTfR Quantikine IVD ELISA Kit
catalog :
DTFR1
quantity :
1 Kit
price :
540 USD
citations: 29
Reference
Lukaszyk E, Lukaszyk M, Koc Zorawska E, Bodzenta Lukaszyk A, Malyszko J. Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?. Arch Med Sci. 2017;13:845-850 pubmed publisher
Wray K, Allen A, Evans E, Fisher C, Premawardhena A, Perera L, et al. Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study. Am J Hematol. 2017;92:196-203 pubmed publisher
Cepeda Lopez A, Allende Labastida J, Melse Boonstra A, Osendarp S, Herter Aeberli I, Moretti D, et al. The effects of fat loss after bariatric surgery on inflammation, serum hepcidin, and iron absorption: a prospective 6-mo iron stable isotope study. Am J Clin Nutr. 2016;104:1030-1038 pubmed
Alwan N, Cade J, McArdle H, Greenwood D, Hayes H, Simpson N. Maternal iron status in early pregnancy and birth outcomes: insights from the Baby's Vascular health and Iron in Pregnancy study. Br J Nutr. 2015;113:1985-92 pubmed publisher
Alwan N, Cade J, McArdle H, Greenwood D, Hayes H, Ciantar E, et al. Infant Arterial Stiffness and Maternal Iron Status in Pregnancy: A UK Birth Cohort (Baby VIP Study). Neonatology. 2015;107:297-303 pubmed publisher
García Valdés L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda M, et al. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Int J Obes (Lond). 2015;39:571-8 pubmed publisher
McDermid J, Hennig B, Van Der Sande M, Hill A, Whittle H, Jaye A, et al. Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis. 2013;13:48 pubmed publisher
Reilly L, Nausch N, Midzi N, Mduluza T, Mutapi F. Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium. J Parasitol Res. 2012;2012:128628 pubmed publisher
Talbot N, Lakhal S, Smith T, Privat C, Nickol A, Rivera Ch M, et al. Regulation of hepcidin expression at high altitude. Blood. 2012;119:857-60 pubmed publisher
Powers H, Hill M, Mushtaq S, Dainty J, Majsak Newman G, Williams E. Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM). Am J Clin Nutr. 2011;93:1274-84 pubmed publisher
Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, Lombardi C, et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood. 2011;117:2953-9 pubmed publisher
Vázquez López M, Llamas M, Galera R, Sanchez A, Lendinez F, Gonzalez Ripoll M, et al. Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants. J Perinatol. 2011;31:118-24 pubmed publisher
Karl J, Lieberman H, Cable S, Williams K, Young A, McClung J. Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation. Am J Clin Nutr. 2010;92:93-100 pubmed publisher
McClung J, Karl J, Cable S, Williams K, Nindl B, Young A, et al. Randomized, double-blind, placebo-controlled trial of iron supplementation in female soldiers during military training: effects on iron status, physical performance, and mood. Am J Clin Nutr. 2009;90:124-31 pubmed publisher
McDermid J, van der Loeff M, Jaye A, Hennig B, Bates C, Todd J, et al. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr. 2009;90:225-33 pubmed publisher
Hunt J, Zito C, Johnson L. Body iron excretion by healthy men and women. Am J Clin Nutr. 2009;89:1792-8 pubmed publisher
Bateman A, McArdle F, Walsh T. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med. 2009;37:1906-12 pubmed publisher
Hill M, Mushtaq S, Williams E, Dainty J, Powers H. Study Protocol: randomised controlled trial to investigate the functional significance of marginal riboflavin status in young women in the UK (RIBOFEM). BMC Public Health. 2009;9:90 pubmed publisher
Sun Q, Ma J, Rifai N, Franco O, Rexrode K, Hu F. Excessive body iron stores are not associated with risk of coronary heart disease in women. J Nutr. 2008;138:2436-41 pubmed publisher
Bouman Thio E, Franson K, Miller B, Getsy J, Cohen A, Bai S, et al. A phase I, single and fractionated, ascending-dose study evaluating the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of an erythropoietin mimetic antibody fusion protein (CNTO 528) in healthy male subjects. J Clin Pharmacol. 2008;48:1197-207 pubmed publisher
Ma A, Schouten E, Zhang F, Kok F, Yang F, Jiang D, et al. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supplements. J Nutr. 2008;138:1946-50 pubmed
Atkinson S, Rockett K, Morgan G, Bejon P, Sirugo G, O Connell M, et al. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood. 2008;112:4276-83 pubmed publisher
Tanno T, Bhanu N, Oneal P, Goh S, Staker P, Lee Y, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13:1096-101 pubmed
Swain J, Johnson L, Hunt J. Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores. J Nutr. 2007;137:620-7 pubmed
Ghio A, Turi J, Madden M, Dailey L, Richards J, Stonehuerner J, et al. Lung injury after ozone exposure is iron dependent. Am J Physiol Lung Cell Mol Physiol. 2007;292:L134-43 pubmed
Chen Y, Hung S, Tarng D. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Am J Kidney Dis. 2006;47:1036-44 pubmed
Capalbo S, Battista C, Delia M, Ciancio A, De Santis G, Dargenio M, et al. Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in B-cell chronic lymphocytic leukemia patients with anemia. Acta Haematol. 2002;108:84-9 pubmed
Shalev H, Kapleushnik Y, Haeskelzon L, Degani O, Kransnov T, Sphilberg O, et al. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults. Eur J Haematol. 2002;68:170-4 pubmed
Fitzsimons E, Houston T, Munro R, Sturrock R, Speekenbrink A, Brock J. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis. Arthritis Rheum. 2002;47:166-71 pubmed
product information
brand :
R&D Systems
master code :
DTFR1
SKU :
DTFR1
product name :
Human sTfR Quantikine IVD ELISA Kit
description :
The Human sTfR Quantikine IVD ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human TfR (Transferrin R) in serum (20 ul), edta plasma (20 ul), heparin plasma (20 ul), citrate plasma (20 ul).
target :
TfR (Transferrin R)
category :
ELISAs
unit size :
1 Kit
species :
Human
specificity :
Measures human sTfR levels in various samples
gene symbol :
TFRC
kit type :
Solid Phase Sandwich ELISA
assay length :
2.5 hours
elisaSampleTypes :
Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL), Citrate Plasma (20 uL)
elisaSensitivity :
0.5 nmol/L
elisaRange :
3.00 - 80 nmol/L
catalog number base :
DTFR1
applications :
ELISA
extended description :
For In Vitro Diagnostic Use
2020 USD :
540
2021 USD :
540 USD
product details :
The Quantikine IVD Human sTfR Immunoassay is designed for the quantitative determination of soluble transferrin receptor (sTfR) concentrations in human serum and plasma as an aid in the diagnosis of Iron-Deficiency Anemia (IDA), especially for the differential diagnosis of IDA and Anemia of Chronic Disease (ACD). For In Vitro Diagnostic Use.
alt names :
CD71, CD71 antigen, CD71TRFR, p90, T9, TfR, TfR (TransferrinR), TFR1, TFRC, TR, transferrin receptor (p90, CD71), transferrin receptor protein 1, Trfr
storage :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.